Value Sense
CVS
CVS Health Corporation (CVS)
Last Price$64.9(1.2%)
Market Cap$82.3B
LTM Total Debt to Total Equity
1.1x
5Y avg
1.1x
Medical - Healthcare Plans industry median
0.2x
Stock quality & Intrinsic value
5/10
2.2% undervalued
CVS
is 220.8% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

CVS Health Corporation Total Debt to Total Equity

Annual
Quarterly
LTM
Industry median
Company stand-alone
CVS
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Total Debt to Total Equity
0.3x
0.5x
0.3x
0.3x
0.3x
0.3x
0.3x
0.3x
0.4x
0.3x
0.7x
0.7x
0.7x
1.3x
1.4x
1.2x
1.0x
1.0x
1.0x
1.1x
CVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CVS and see if it's the right time to invest.
Dive in

CVS Health Corporation (CVS) Total Debt to Total Equity comparison analysis

General

LTM Total Debt to Total Equity

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

CVS Health Corporation logo
CVS Health CorporationCVS
1.1x
4.2%
(43.6%)
1.2%
Median Peer Set
0.2x
8.7%
(2.4%)
1.5%
Cigna Corporation logo
Cigna CorporationCI
0.8x
8.4%
(18.9%)
2.6%
Humana Inc. logo
Humana Inc.HUM
0.7x
10.7%
(50.1%)
1.0%
Centene Corporation logo
Centene CorporationCNC
0.7x
5.9%
27.4%
2.0%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
0.7x
19.3%
9.2%
2.9%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
0.3x
56.5%
N/A
0.3%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
0.1x
27.2%
(4.8%)
(8.1%)
Elevance Health Inc. logo
Elevance Health Inc.ELV
0.0x
3.2%
(0.0%)
3.4%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
0.0x
8.9%
(35.7%)
3.6%
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
0.0x
(41.5%)
(31.3%)
(10.5%)
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
(1.5x)
(51.9%)
86.2%
(103.4%)

CVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
37,006.7
21.0%
43,821.4
18.4%
76,329.5
74.2%
87,472.0
14.6%
98,215.0
12.3%
95,778.0
(2.5%)
107,080.0
11.8%
123,120.0
15.0%
126,761.0
3.0%
139,367.0
9.9%
153,290.0
10.0%
177,546.0
15.8%
184,786.0
4.1%
194,579.0
5.3%
256,776.0
32.0%
268,706.0
4.6%
292,111.0
8.7%
322,467.0
10.4%
357,776.0
10.9%
372,809.0
4.2%
Cost of Goods Sold (COGS)27,312.132,079.260,221.869,182.077,857.075,559.086,518.0100,632.0102,978.0114,000.0126,762.0148,712.0156,258.0163,041.0211,248.0219,660.0239,991.0267,965.0303,345.0321,408.0
Gross Profit
% margin
9,694.6
26.2%
11,742.2
26.8%
16,107.7
21.1%
18,290.0
20.9%
20,358.0
20.7%
20,219.0
21.1%
20,562.0
19.2%
22,488.0
18.3%
23,783.0
18.8%
25,367.0
18.2%
26,528.0
17.3%
28,834.0
16.2%
28,528.0
15.4%
31,538.0
16.2%
45,528.0
17.7%
49,046.0
18.3%
52,120.0
17.8%
54,502.0
16.9%
54,431.0
15.2%
51,401.0
13.8%
Operating Expenses7,675.19,300.611,314.412,244.013,933.014,082.014,231.015,278.015,746.016,568.017,053.018,448.018,990.027,517.033,541.035,135.038,810.046,548.040,688.041,606.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)7,675.19,300.611,314.412,244.213,933.014,092.014,231.00.00.00.00.00.00.00.00.00.00.00.00.0(1,279.0)
Operating Income
% margin
2,019.5
5.5%
2,441.6
5.6%
4,793.3
6.3%
6,046.0
6.9%
6,425.0
6.5%
6,137.0
6.4%
6,331.0
5.9%
7,210.0
5.9%
8,037.0
6.3%
8,799.0
6.3%
9,475.0
6.2%
10,386.0
5.8%
9,538.0
5.2%
4,021.0
2.1%
11,987.0
4.7%
13,911.0
5.2%
13,310.0
4.6%
7,954.0
2.5%
13,743.0
3.8%
8,516.0
2.3%
Interest Income0.00.00.021.05.03.04.04.08.015.021.020.021.00.00.00.00.00.00.00.0
Interest Expense0.00.00.0530.0530.0539.0588.0561.0517.0615.0859.01,078.01,062.02,619.03,035.02,907.02,503.02,287.02,658.02,958.0
Pre-tax Income1,909.02,225.84,358.75,537.05,900.05,601.05,747.06,305.07,528.07,678.08,616.08,637.08,268.01,406.08,997.09,770.010,537.05,836.011,173.06,148.0
Income Tax
% effective tax rate
684.3
35.8%
856.9
38.5%
1,721.7
39.5%
2,193.0
39.6%
2,200.0
37.3%
2,179.0
38.9%
2,258.0
39.3%
2,436.0
38.6%
2,928.0
38.9%
3,033.0
39.5%
3,386.0
39.3%
3,317.0
38.4%
1,637.0
19.8%
2,002.0
142.4%
2,366.0
26.3%
2,569.0
26.3%
2,548.0
24.2%
1,509.0
25.9%
2,805.0
25.1%
1,562.0
25.4%
Net Income
% margin
1,224.7
3.3%
1,368.9
3.1%
2,637.0
3.5%
3,212.0
3.7%
3,696.0
3.8%
3,427.0
3.6%
3,462.0
3.2%
3,864.0
3.1%
4,592.0
3.6%
4,644.0
3.3%
5,237.0
3.4%
5,317.0
3.0%
6,622.0
3.6%
(594.0)
(0.3%)
6,634.0
2.6%
7,179.0
2.7%
8,001.0
2.7%
4,311.0
1.3%
8,344.0
2.3%
4,614.0
1.2%
EPS1.491.651.972.232.582.512.593.053.773.984.664.936.47(0.57)5.105.486.003.296.493.66
Diluted EPS1.451.601.922.182.552.492.573.033.743.964.634.906.44(0.57)5.085.465.953.266.473.66
EBITDA
% margin
2,608.6
7.0%
3,174.9
7.2%
5,887.9
7.7%
7,341.0
8.4%
7,819.0
8.0%
7,609.0
7.9%
7,903.0
7.4%
8,619.0
7.0%
9,915.0
7.8%
10,224.0
7.3%
11,567.0
7.5%
12,190.0
6.9%
11,809.0
6.4%
6,743.0
3.5%
16,403.0
6.4%
17,118.0
6.4%
17,526.0
6.0%
12,347.0
3.8%
18,197.0
5.1%
13,703.0
3.7%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is CVS Health Corporation's Total Debt to Total Equity?

As of today, Microsoft Corp's last 12-month Total Debt to Total Equity is 1.1x, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Total Debt to Total Equity for CVS Health Corporation have been 1.1x over the past three years, and 1.2x over the past five years.

2) Is CVS Health Corporation's Total Debt to Total Equity Good?

As of today, CVS Health Corporation's Total Debt to Total Equity is 1.1x, which is higher than industry median of 0.2x. It indicates that CVS Health Corporation's Total Debt to Total Equity is Bad.

3) How does CVS Health Corporation's Total Debt to Total Equity compare to its peers?

As of today, CVS Health Corporation's Total Debt to Total Equity is 1.1x, which is higher than peer median of 0.2x. The list of peers includes CI, HUM, CNC, MOH, OSCR, ALHC, ELV, UNH, CLOV, BHG.